Inventor · disambiguated record
William J. Greenlee
Also filed as: GREENLEE WILLIAM · GREENLEE WILLIAM J · GREENLEE WILLIAM JOHN
161 granted patents·42 pending applications·2,977 citations·filing 1979–2025
99Inventor score
Files withMERCK & CO INC69SCHERING CORP25ZHU ZHAONING16ACHILLION PHARMACEUTICALS INC14UNIV CASE WESTERN RESERVE11
Top patents by PatentIndex Score
203 records- 0198US11708351B2Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2021·Granted Jul 25, 2023·8 cites·17 claims
- 0298US11407738B2Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disordersACHILLION PHARMACEUTICALS INC·Filed 2020·Granted Aug 9, 2022·16 cites·12 claims
- 0398US11084800B2Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2019·Granted Aug 10, 2021·18 cites·11 claims
- 0498US10919884B2Amide compounds for treatment of immune and inflammatory disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted Feb 16, 2021·20 cites·12 claims
- 0598US10906887B2Amino compounds for treatment of immune and inflammatory disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted Feb 2, 2021·20 cites·12 claims
- 0698US10662175B2Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted May 26, 2020·20 cites·20 claims
- 0798US5332744ASubstituted imidazo-fused 6-membered heterocycles as angiotensin II antagonistsMERCK & CO INC·Filed 1990·Granted Jul 26, 1994·190 cites·21 claims
- 0897US12006307B2Pharmaceutical compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2022·Granted Jun 11, 2024·3 cites·7 claims
- 0997US11447465B2Pharmaceutical compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2019·Granted Sep 20, 2022·16 cites·8 claims
- 1097US10807952B2Compounds for treatment of immune inflammatory disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted Oct 20, 2020·20 cites·13 claims
- 1197US4576748A3-Hydroxy-3-aminoethyl β-lactamsMERCK & CO INC·Filed 1984·Granted Mar 18, 1986·49 cites·3 claims
- 1296US12162860B2Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2023·Granted Dec 10, 2024·2 cites·20 claims
- 1396US5312820ASubstituted carbamoyl and oxycarbonyl derivatives of biphenylmethylaminesMERCK & CO INC·Filed 1992·Granted May 17, 1994·111 cites·22 claims
- 1496US5064825AAngiotensin ii antagonistsMERCK & CO INC·Filed 1990·Granted Nov 12, 1991·87 cites·9 claims
- 1595US11649229B2Amide compounds for treatment of immune and inflammatory disordersACHILLION PHARMACEUTICALS INC·Filed 2020·Granted May 16, 2023·3 cites·20 claims
- 1695US11649223B2Amino compounds for treatment of immune and inflammatory disordersACHILLION PHARMACEUTICALS INC·Filed 2020·Granted May 16, 2023·3 cites·20 claims
- 1795US7763609B2Heterocyclic aspartyl protease inhibitorsSCHERING CORP·Filed 2007·Granted Jul 27, 2010·38 cites·12 claims
- 1895US5527819AInhibitors of HIV reverse transcriptaseMERCK & CO INC·Filed 1995·Granted Jun 18, 1996·109 cites·9 claims
- 1995US5334598ASix-membered ring fused imidazoles substituted with phenoxyphenylacetic acid derivativesMERCK & CO INC·Filed 1993·Granted Aug 2, 1994·101 cites·8 claims
- 2094US6630475B2Adenosine A2a receptor antagonistsSCHERING CORP·Filed 2001·Granted Oct 7, 2003·53 cites·17 claims
- 2193US5223499A6-amino substituted imidazo[4,5-bipyridines as angiotensin II antagonistsMERCK & CO INC·Filed 1992·Granted Jun 29, 1993·151 cites·18 claims
- 2292US7304078B2Thrombin receptor antagonistsSCHERING CORP·Filed 2003·Granted Dec 4, 2007·43 cites·67 claims
- 2391US10787454B2Imidazo[1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disordersBIAL BIOTECH INVEST INC·Filed 2017·Granted Sep 29, 2020·10 cites·24 claims
- 2491US9789116B2Compositions and methods of modulating short-chain dehydrogenase activityUNIV CASE WESTERN RESERVE·Filed 2014·Granted Oct 17, 2017·16 cites·15 claims
- 2591US6894063B2Substituted urea neuropeptide Y Y5 Receptor antagonistsSCHERING CORP·Filed 2002·Granted May 17, 2005·24 cites·17 claims
- 2691US5668176APhenoxyphenylacetic acid derivativesMERCK & CO INC·Filed 1996·Granted Sep 16, 1997·59 cites·14 claims
- 2791US5348955AN,N-diacylpiperazinesMERCK & CO INC·Filed 1993·Granted Sep 20, 1994·53 cites·5 claims
- 2891US5292726AN,N-diacylpiperazinesMERCK & CO INC·Filed 1992·Granted Mar 8, 1994·62 cites·16 claims
- 2991US5240928ASubstituted quinazolinones as angiotensin II antagonistsMERCK & CO INC·Filed 1991·Granted Aug 31, 1993·55 cites·14 claims
- 3091US5124335ASubstituted pyrollo-fused 6 membered heterocycles as angiotensin ii antagonistsMERCK & CO INC·Filed 1991·Granted Jun 23, 1992·95 cites·12 claims
- 3191US5102880ASubstituted imidazo-fused 6-membered heterocycles as angiotensin II antagonistsMERCK & CO INC·Filed 1991·Granted Apr 7, 1992·54 cites·5 claims
- 3291US2025243217A1Compositions and methods of modulating short-chain dehydrogenase activityUNIV CASE WESTERN RESERVE·Filed 2024·Application pending·0 cites
- 3390US11453675B2Imidazo[1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disordersBIAL—R&D INVEST S A·Filed 2020·Granted Sep 27, 2022·2 cites·18 claims
- 3490US11168087B2Substituted imidazo[1,2-b]pyridazines, substituted imidazo[1,5-b]pyridazines, related compounds, and their use in the treatment of medical disordersBIAL—R&D INVEST S A·Filed 2017·Granted Nov 9, 2021·4 cites·18 claims
- 3590US8907095B2Bicyclic heterocycle derivatives and their use as modulators of the activity of GPR119XIA YAN·Filed 2008·Granted Dec 9, 2014·23 cites·14 claims
- 3690US7868000B2Aspartyl protease inhibitorsSCHERING CORP·Filed 2006·Granted Jan 11, 2011·18 cites·45 claims
- 3790US5124327AHIV reverse transcriptaseMERCK & CO INC·Filed 1991·Granted Jun 23, 1992·75 cites·1 claims
- 3889US12098135B2Aldoketo reductase inhibitors and uses thereofUNIV CASE WESTERN RESERVE·Filed 2022·Granted Sep 24, 2024·1 cites·15 claims
- 3989US11878979B2Substituted imidazo[1,2-b]pyridazines, substituted imidazo[1,5-b]pyridazines, related compounds, and their use in the treatment of medical disordersBIAL—R&D INVEST S A·Filed 2021·Granted Jan 23, 2024·1 cites·22 claims
- 4089US5559135AEndothelin antagonists bearing pyridyl amidesMERCK & CO INC·Filed 1994·Granted Sep 24, 1996·40 cites·8 claims
- 4189US5538991AEndothelin antagonists bearing 5-membered heterocyclic amidesMERCK & CO INC·Filed 1994·Granted Jul 23, 1996·41 cites·22 claims
- 4289US5412097AHeterocyclic compounds bearing acidic functional groups as angiotensin II antagonistsMERCK & CO INC·Filed 1992·Granted May 2, 1995·43 cites·15 claims
- 4389US5411980ASubstituted triazolinones, triazolinethiones, and triazolinimines as angiotensin II antagonistsMERCK & CO INC·Filed 1992·Granted May 2, 1995·45 cites·9 claims
- 4488US12338230B2Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disordersACHILLION PHARMACEUTICALS INC·Filed 2024·Granted Jun 24, 2025·0 cites·16 claims
- 4588US7700603B2Heterocyclic aspartyl protease inhibitorsSCHERING CORP·Filed 2005·Granted Apr 20, 2010·9 cites·8 claims
- 4688US5264439AQuinazolinone, triazolinone and pyrimidinone angiotensin II antagonists incorporating a substituted benzyl elementMERCK & CO INC·Filed 1991·Granted Nov 23, 1993·38 cites·8 claims
- 4788US5157026AOxo-purines as angiotensin II antagonistsMERCK & CO INC·Filed 1992·Granted Oct 20, 1992·38 cites·6 claims
- 4887US8183252B2Heterocyclic aspartyl protease inhibitorsZHU ZHAONING·Filed 2010·Granted May 22, 2012·8 cites·88 claims
- 4987US7700597B2Substituted piperazines as CB1 antagonistsSCHERING CORP·Filed 2005·Granted Apr 20, 2010·9 cites·50 claims
- 5087US5565485ABiphenyl compounds useful or endothelin antagonistsMERCK & CO INC·Filed 1994·Granted Oct 15, 1996·32 cites·23 claims
Showing the top 50 of 203 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when William J. Greenlee files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →